Rimon Gold Assets Ltd insider trades: Wize Pharma (WIZP) stock purchases
Trades on the price chart
Daily close, with an arrow on each day they bought or sold
Companies
Where Rimon Gold Assets Ltd reports to the SEC
Open-market buys and sales
2 trades reported on SEC Form 4, newest first
| Date | Stock | Type | Shares | Price | Value | Holding | Reported |
|---|---|---|---|---|---|---|---|
| Mar 9, 2021 | WIZP | ↑ Buy | 10,833,333 | $0.12 | $1.3M | Direct | Mar 11, 2021 (2d) |
| Oct 24, 2018 | WIZP | ↑ Buy | 400,000 | $1.00 | $400K | Direct | Feb 6, 2020 (470d) |
Each row is one filing's trades in one stock, summed. Shares and prices are as filed, before any later stock split.
About Rimon Gold Assets Ltd's insider trades
Rimon Gold Assets Ltd is a 10% owner of Wize Pharma (WIZP). Since Oct 24, 2018, it has reported 2 open-market purchases worth $1.7M and no sales on SEC Form 4. There have been no open-market trades in the last 12 months.
Its filings also include conversions (2 filings), option exercises (1 filing), other transactions (1 filing). These aren't open-market trades and aren't counted above.
How to read insider trades
Officers, directors and owners of more than 10% of a company must report trades in its stock on SEC Form 4, usually within two business days. Purchases with their own money are the stronger signal: insiders sell for many reasons (taxes, diversification, a house), but buy for one. See every WIZP insider trade, the latest insider trades across the market, or cluster buys, when several insiders buy the same stock within days.